Cite
APA Citation
Savona, M., Garcia-Manero, G., Roboz, G., Walsh, K., Kropf, P., Issa, J., O'Connell, C., Tibes, R., Yee, K., Stock, W., Lunin, S., Berdeja, J., Naim, S., Hao, Y., Azab, M., & Kantarjian, H. (n.d.). randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML). Leukemia research, 55, S40–S41. http://access.bl.uk/ark:/81055/vdc_100045920464.0x00003a